Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled Pilot Study of Genistein Supplementation in Pediatric Cancer Patients Receiving Myelosuppressive Chemotherapy

NCT02624388 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT02624388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02624388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled Pilot Study of Genistein Supplementation in Pediatric Cancer Patients Receiving Myelosuppressive Chemotherapy
Lead sponsor
University of Virginia
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2016
Completion date
September 30, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain neoplasms, childhood lymphoma, childhood solid tumor, ewing sarcoma, germ cell tumor, hodgkin lymphoma, lymphoma, medulloblastoma, medulloblastoma, childhood, neuroblastoma, neuroectodermal tumors, primitive, non-hodgkin lymphoma, rhabdomyosarcoma, soft tissue sarcoma, solid tumor, wilms tumor